Aradigm (ARDM) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.15▼$0.3852-Week Range N/AVolumeN/AAverage Volume97,091 shsMarket Capitalization$761,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFirst International Bank of Israel Ltd (FIBI)investing.com - November 21 at 5:20 PMAltshuler Shaham Financial LTD (ALTF)investing.com - November 10 at 10:47 AMNon-Cystic Fibrosis Bronchiectasis Market Forecast to 2030marketwatch.com - May 1 at 12:20 AMAerodrome Group Ltd (ARDM)investing.com - April 22 at 2:58 PMAerodrome Group Ltd (ARDM.TA)finance.yahoo.com - March 17 at 3:41 PMHow and Why Google Glass Failedinvestopedia.com - December 28 at 12:21 AMAradigm Announces Effective Date of Modified Combined Chapter 11 Plan and Disclosure Statementfinance.yahoo.com - June 15 at 9:46 PMAradigm Announces Conditional Approval for the Combined Chapter 11 Plan and Disclosure Statementwww.businesswire.com - April 30 at 6:03 PMSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Aradigm Corporatiwww.bloomberg.com - March 15 at 6:11 PMAradigm Announces Entering into an Asset Purchase Agreement with Grifols, S.A.finance.yahoo.com - February 21 at 12:28 PMAradigm Announces Withdrawal of European Marketing Authorization Application (MAA) for Linhaliqfinance.yahoo.com - October 30 at 7:02 PM3 Stocks Pushing The Health Care Sector Lowerwww.thestreet.com - October 11 at 10:40 PMAradigm Corpwww.bloomberg.com - February 24 at 8:17 AMAradigm Announces Receipt of Final FDA Minutes for the Type B Meeting on January 25, 2019finance.yahoo.com - February 22 at 8:22 AMAradigm files for bankruptcy in Californiaseekingalpha.com - February 16 at 8:18 AMAradigm Announces Plans for Reorganization Under Chapter 11 of the U.S. Bankruptcy Codefinance.yahoo.com - February 16 at 8:18 AMAradigm advancing European marketing application for Apulmiqseekingalpha.com - January 30 at 7:04 PMAradigm Announces Submission of Responses to EMA Day 120 Questions and Meeting with FDAfinance.yahoo.com - January 30 at 8:13 AMAradigm to meet with FDA to get Apulmiq NDA back on trackseekingalpha.com - January 16 at 5:55 PMAradigm Announces Detailed Third Party Evaluation Results for Apulmiq (FDA)/Linhaliq (EMA)finance.yahoo.com - January 16 at 8:19 AMThird party verification of Aradigm's late-stage studies of inhalable ciprofloxacin completed; shares up 2%seekingalpha.com - December 20 at 5:38 PMAradigm Announces Results of Third Party Verification for Apulmiq (formerly Linhaliq)finance.yahoo.com - December 20 at 8:19 AM Get Aradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDM and its competitors with MarketBeat's FREE daily newsletter. Email Address ARDM Media Mentions By Week ARDM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARDM News Sentiment▼0.000.84▲Average Medical News Sentiment ARDM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARDM Articles This Week▼10▲ARDM Articles Average Week Get Aradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Nuwellis News Today ENDRA Life Sciences News Today SciSparc News Today PaxMedica News Today China SXT Pharmaceuticals News Today Aditxt News Today Evofem Biosciences News Today Clearmind Medicine News Today Baudax Bio News Today ContraFect News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ARDM) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aradigm Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.